What is the official website of Seattle Vaccine Trials Unit ?

The official website of Seattle Vaccine Trials Unit is www.seattlevaccines.org.

What is Seattle Vaccine Trials Unit's cybersecurity risk score?

Seattle Vaccine Trials Unit has an AI-generated cybersecurity risk score of 751 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Seattle Vaccine Trials Unit experienced?

According to Rankiteo, Seattle Vaccine Trials Unit currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Seattle Vaccine Trials Unit been affected by any supply chain cyber incidents ?

According to Rankiteo, Seattle Vaccine Trials Unit has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Seattle Vaccine Trials Unit have SOC 2 Type 1 certification ?

According to Rankiteo, Seattle Vaccine Trials Unit is not certified under SOC 2 Type 1.

Does Seattle Vaccine Trials Unit have SOC 2 Type 2 certification ?

According to Rankiteo, Seattle Vaccine Trials Unit does not hold a SOC 2 Type 2 certification.

Does Seattle Vaccine Trials Unit comply with GDPR ?

According to Rankiteo, Seattle Vaccine Trials Unit is not listed as GDPR compliant.

Does Seattle Vaccine Trials Unit have PCI DSS certification ?

According to Rankiteo, Seattle Vaccine Trials Unit does not currently maintain PCI DSS compliance.

Does Seattle Vaccine Trials Unit comply with HIPAA ?

According to Rankiteo, Seattle Vaccine Trials Unit is not compliant with HIPAA regulations.

Does Seattle Vaccine Trials Unit have ISO 27001 certification ?

According to Rankiteo,Seattle Vaccine Trials Unit is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Seattle Vaccine Trials Unit operate in ?

Seattle Vaccine Trials Unit operates primarily in the Biotechnology Research industry.

How many employees does Seattle Vaccine Trials Unit have ?

Seattle Vaccine Trials Unit employs approximately None employees people worldwide.

Does Seattle Vaccine Trials Unit own any subsidiaries ?

Seattle Vaccine Trials Unit presently has no subsidiaries across any sectors.

How many LinkedIn followers does Seattle Vaccine Trials Unit have ?

Seattle Vaccine Trials Unit's official LinkedIn profile has approximately 405 followers.

What is the NAICS classification code for Seattle Vaccine Trials Unit ?

Seattle Vaccine Trials Unit is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Seattle Vaccine Trials Unit have a Crunchbase profile ?

No, Seattle Vaccine Trials Unit does not have a profile on Crunchbase.

Does Seattle Vaccine Trials Unit have a LinkedIn profile ?

Yes, Seattle Vaccine Trials Unit maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/seattle-vaccine-trials-unit.

How many cybersecurity incidents has Seattle Vaccine Trials Unit experienced ?

As of June 27, 2026, Rankiteo reports that Seattle Vaccine Trials Unit has experienced 4 cybersecurity incidents.

How many peer or competitor companies does Seattle Vaccine Trials Unit have ?

Seattle Vaccine Trials Unit has an estimated 4,711 peer or competitor companies worldwide.

What types of cybersecurity incidents has Seattle Vaccine Trials Unit faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Ransomware and Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

SVTU

Boost Score +25 with badge (5 left)

751

/1000

Fair

776

/1000

Fair

Seattle Vaccine Trials Unit Vendor Cyber Rating & Cyber Score

seattlevaccines.org

Add Your Compliance Badge

There’s no doubt the world is desperately in need of more options to help prevent HIV. Seattle Vaccine Trials Unit (VTU) is leading the fight against major diseases of today such as COVID-19 and HIV. We conduct clinical research studies to promote heathier protected communities. You can make an impact by joining our team to work with study volunteers who are making a difference in the world of research. LINKTREE: https://linktr.ee/seattlevtu

SVTU A.I CyberSecurity Scoring

Scoring History

SVTU

Seattle Vaccine Trials Unit CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Seattle Vaccine Tri...

Ransomware

12/2023

FRE144171223

Seattle Vaccine Tri...

Ransomware

100

11/2023

FRE226432211282...

Seattle Vaccine Tri...

Breach

10/2023

FRE106080425

Seattle Vaccine Tri...

Breach

3/2022

FRE650072625

Loading…

A.I.

SVTU Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for SVTU

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Seattle Vaccine Trials Unit in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Seattle Vaccine Trials Unit in 2026.

Incident Types SVTU vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Seattle Vaccine Trials Unit in 2026.

Incident History - SVTU (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Seattle Vaccine Trials Unit Subsidiaries

SVTU

Biotechnology Research

Website: www.seattlevaccines.org

Company Size: None employees

Fred HutchHospitals and Health Care

Fred Hutch Cord Blood Transplant ProgramHospitals and Health Care

Biostatistics Program at Fred HutchBiotechnology Research

Innovators NetworkNon-profit Organization Management

Seattle Cancer Care AllianceHospitals and Health Care

ObliteridePhilanthropic Fundraising Services

Loading…

Seattle Vaccine Trials Unit Similar Companies

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Genentech

gene.com

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Loading…

NEWS

Seattle Vaccine Trials Unit CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

May 11, 2020 07:00 AM

The ‘biggest challenge’ won’t come until after a coronavirus vaccine is found

Meeting the overwhelming demand for a successful coronavirus vaccine will require a historic amount of coordination by scientists, drugmakers and the...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-56414

SUMMARY

A vulnerability exists in H.View IP cameras certificate-related upload interfaces allow authenticated users to store arbitrary file content to fixed, persistent filesystem locations without validating file type, structure, or size. This design omission enables the placement of unexpected or malformed data in locations intended for trusted certificate material, which could affect system integrity or behavior even after reboot.

Published

Date2026-06-26

Updated

Date2026-06-26

RISK INFORMATION (Score: 7.2)

cvss3

Base Score: 7.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

1.2

REFERENCES

CVE-2026-55975

SUMMARY

A vulnerability exists in H.View IP cameras that could allow an authenticated user to supply unsanitized XML fields to the device's certificate generation interface, which are incorporated into a backend certificate creation command without proper input validation. This may allow for command execution with elevated privileges during certificate generation.

Published

Date2026-06-26

Updated

Date2026-06-26

RISK INFORMATION (Score: 7.2)

cvss3

Base Score: 7.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

1.2

REFERENCES

CVE-2026-33560

SUMMARY

The DMP-5000 file service exposes authenticated arbitrary file upload functionality. There are exposed endpoints which allows authenticated users to upload files of any type without validation. No file extension filtering or content inspection is enforced which allows executable binaries and scripts to be accepted and written directly to the server.

Published

Date2026-06-26

Updated

Date2026-06-26

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:H/A:N

cvss4

Base Score: 8.4

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:H/VA:N/SC:L/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.2

Exploitability

2.8

REFERENCES

CVE-2026-31928

SUMMARY

The DMP-5000 devices are shipped with a default administrative web account with weak authentication controls, which are not required to be changed during initial configuration or operation. Using these accounts provides full system access.

Published

Date2026-06-26

Updated

Date2026-06-26

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:N/SC:H/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

2.8

REFERENCES

CVE-2026-28701

SUMMARY

Various versions of Daktronics Controller Firmware could allow authenticated and unauthenticated remote users to escape the intended directory and enumerate arbitrary file system paths.

Published

Date2026-06-26

Updated

Date2026-06-26

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…